The $66 million project is part of the company's obligation made to the state after it moved here to invest a total of $120 ...
Spending the day facing the challenges of kidney patients helps workers at a CT pharmaceutical company understand disease and ...
A new survey shows that three Big Pharmas have stolen the hearts of patient groups representing nearly 1 million people with cardiovascular conditions. | A new survey shows that three Big Pharmas have ...
Indigo Ag has hired a new chief financial officer, while a biotech developing a potential epilepsy drug got a Series A as ...
The state-of-the-art research and development center in Georgia will help improve the health and wellbeing of animals ...
With a capital investment of US$66.1 million and 63 new jobs created, this expansion includes the addition of 63,000 square feet of administrative space and more than 28,000 square feet of laboratory ...
Bracknell Forest Councillors will face criminal record checks in a move made by only a few other councils across the country. Disclosure and Barring Service (DBS) checks will be carried out on all ...
Sadness for staff but anger at how the brand has been allowed to go downhill - residents across Bracknell have reacted to the closure of TGI Fridays in Bracknell. On Monday, October 7 ...
Notable Labs’ attempts to take a Boehringer Ingelheim cancer drug to market appear to have come to end with the oncology-focused platform company’s decision to file for bankruptcy. Notable's ...
Boehringer Ingelheim partners with the WHO Foundation to financially support WHO’s Fourteenth General Programme of Work (2025 to 2028). Credit: PeopleImages.com – Yuri A/Shutterstock. Boehringer ...
Boehringer Ingelheim focuses on targeting the proteins involved in this process as a promising strategy for developing new cancer treatments. Credit: Tada Images/Shutterstock. Boehringer Ingelheim and ...
INGELHEIM, Germany & SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Boehringer Ingelheim and Circle Pharma (Circle) announce a new research collaboration and license agreement with the shared goal ...